Importance of rapid PEP: predicting impact of delay and duration of 2- and 3-drug PEP
23 November 2025. Related: Journal scan, HIV prevention and transmission.
Journal scan
Short reports on recently published research
Case of functional cure reported in an elite controller after 22 years without ART
23 November 2025. Related: Journal scan, Cure-related research.
Lenacapavir drug resistance: rapid switching and the need for resistance testing
23 November 2025. Related: Journal scan, Antiretrovirals, Drug resistance.
Australian survey reports limited interest in CAB-LA PrEP by gay and bisexual men
22 November 2025. Related: Journal scan, Treatment access, HIV prevention and transmission.
Call to drop abacavir from use in adults
13 July 2025. Related: Journal scan, Antiretrovirals, Treatment strategies, Coinfections and complications.
Risk of metabolic syndrome when starting ART with bictegravir vs dolutegravir
7 June 2025. Related: Journal scan, Side effects, Weight, diabetes, metabolic complications.
Featured Latest news on the US crisis and its impact on global health
1 June 2025. Related: Journal scan, Special reports, Treatment access, Activism & advocacy.
Vaccination is effective in limiting mpox progression – but lower efficacy in people living with HIV
27 May 2025. Related: Journal scan, mpox.
HIV activists in the US call for action in JID and Zachie Achmat brings South African perspective in the Lancet
26 May 2025. Related: Journal scan, Treatment access, Activism & advocacy.
Combining injectable lenacapavir and cabotegravir-LA
23 May 2025. Related: Journal scan, Antiretrovirals, Treatment strategies, Treatment access.
Viral failure on CAB/RPV-LA: overcoming drug resistance with second-generation INSTIs
13 April 2025. Related: Journal scan, Treatment strategies, Drug resistance.
Lancet Commission on gender justice and equality
9 April 2025. Related: Journal scan.
Lancet HIV recognises Transgender Day of Visibility and the importance of gender-affirming hormones in HIV care
3 April 2025. Related: Journal scan, Special reports, Treatment access.